Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,243 | 59,809 | 127,636 | 143,251 | 159,087 |
| Marketable Securities | 139,980 | 138,341 | 116,055 | 117,055 | 101,860 |
| Receivables | 24,467 | 25,158 | 22,987 | 21,235 | 26,841 |
| Other current assets | 4,503 | 7,333 | 5,147 | 5,528 | 6,643 |
| TOTAL | $221,193 | $230,641 | $271,825 | $287,069 | $294,431 |
| Non-Current Assets | |||||
| PPE Net | 41,198 | 42,790 | 44,451 | 45,895 | 48,956 |
| Investments And Advances | 35,736 | 35,491 | 5,262 | 7,521 | 7,651 |
| Intangibles | 845 | 1,153 | 242 | 1,116 | 691 |
| Other Non-Current Assets | 44,073 | 43,892 | 42,307 | 41,944 | 44,148 |
| TOTAL | $121,852 | $123,326 | $92,262 | $96,476 | $101,446 |
| Total Assets | $343,045 | $353,966 | $364,086 | $383,544 | $395,876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,240 | 18,230 | 16,786 | 16,134 | 5,350 |
| Accounts payable and accrued liabilities | 16,095 | 17,522 | 17,209 | 18,664 | 18,511 |
| Other current liabilities | 11,902 | 10,824 | 7,408 | 10,925 | 11,275 |
| TOTAL | $148,577 | $167,432 | $162,569 | $166,269 | $165,650 |
| Non-Current Liabilities | |||||
| Long Term Debt | 63,399 | 55,856 | 51,037 | 50,882 | 61,575 |
| Deferred Revenues | 94,008 | 113,379 | 113,304 | 112,161 | 122,006 |
| Other Non-Current Liabilities | 30,591 | 33,567 | 34,277 | 35,360 | 39,110 |
| TOTAL | $93,990 | $89,423 | $85,314 | $86,242 | $100,803 |
| Total Liabilities | $242,567 | $256,855 | $247,883 | $252,511 | $266,452 |
| Shareholders' Equity | |||||
| Common Shares | 5,902 | 5,902 | 5,900 | 5,889 | 5,906 |
| Retained earnings | -307,861 | -308,455 | -347,691 | -329,607 | -448,481 |
| Other shareholders' equity | -32,725 | -33,885 | -37,271 | -39,537 | -35,154 |
| TOTAL | $100,478 | $97,111 | $116,204 | $131,033 | $129,424 |
| Total Liabilities And Equity | $343,045 | $353,966 | $364,087 | $383,544 | $395,876 |